Abstract
Forty-three patients with invasive adenocarcinoma of the gallbladder were postoperatively studied in order to determine their general immunological status as well as the local immunohistological reaction to the tumor. At the end of the follow-up, they formed two groups: 19 living patients (group GL) and 24 dead patients (group GD). As a control group (GC), 21 patients with cholecistectomy for cholelithiasis and without carcinoma were simultaneously evaluated. In GL, most of the tumors were limited to the gallbladder wall, and in GD, most of the tumors were already disseminated at the time of diagnosis. GD presented a lower percentage of peripheral blood B lymphocytes, as compared to GL and GC cases. Skin tests of delayed hypersensitivity were significantly more reactive in GL cases than in GD cases, and less reactive in GD than in GC cases. The immunohistological evaluation of the gallbladder yielded a lower B lymphocyte infiltration in GD tumors than in the control cases. GL cases showed a higher intratumoral lymphocytic and mononuclear cell infiltration than GD cases. Although the clinical stage was higher in GD than in GL cases, there were also significant differences in the local immune response and the general immunological status. Patients with invasive gallbladder adenocarcinoma showing longer postoperative survival revealed normal or increased local and general immunological reactions, whereas patients with disseminated tumors showed an important humoral and cellular secondary immunodeficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergdahl L (1980) Gallbladder carcinoma first diagnosed at microscopic examination of gallbladders removed for presumed benign disease. Ann Surg 191:19–22
Betzler M, Herfarth CH (1986) Immunologie in Diagnose und Behandlung chirurgischer Krankheitsbilder. In Grundlagen der Chirurgie, Heft 5, Mitteilungen der Deutschen Gesellschaft für Chirurgie
Chattopadhyay TK, Kumar A, Kapoor VK, Sharma LK, Kapur MM, Kapur BM, Dhawan IK (1988) Carcinoma of the gallbladder—can we do anything? Postgrad Med J 64:593
Cubillos L, Duarte I, Quappe G, Alfaro E, Ferreiro O (1987) Cáncer de la vesícula biliar. Estudio anatomoclínico de 100 casos. Rev Chil Cir 39:201–207
Cubillos L, Paladines G, González S, Cruz F, Rivero S, Sepúlveda C, Rodríguez L, Ferreiro O, Martínez I, Valdés C (1990) Evaluación inmunológica e inmunogenética de pacientes con cáncer de la vesícula biliar. Comunicación preliminar. Rev Chil Cir 42:157–166
Davila M, Silva M, Rufin F, Ruiz F, Ugarte JM, Díaz H (1974) Estudio de la inmunidad celular y humoral en sujetos normales y en pacientes con cáncer gástrico, úlcera gástrica y gastritis crónica. Rev. Med Chil 102:353–358
De Aretxabala X, Burgos L, Roa I, Araya J, Wistuba I, Flores P, Fonseca L (1991) Cáncer vesicular: manejo de estadios potencialmente curativos. Rev Chil Cir 43:199–203
Dillman R, Koziol J, Zavanelli M, Beauregard J, Halliburton B, Glassy M, Royston I (1984) Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer 53:1484–1491
Eilber FR, Morton DL (1970) Impaired immunologic reactivity and recurrence following cancer surgery. Cancer 25:362–367
Eilber FR, Nizze JA, Morton DL (1975) Sequential evaluation of general immune competence in cancer patients: correlation with clinical course. Cancer 35:660–665
Gagner M, Rossi RL (1991) Radical operations for carcinoma of the gallbladder: present status in North America. World J Surg 15:344–347
Gall FP, Köckerling F, Scheele J, Schneider C, Hohenberger W (1991) Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg 15:328–336
Hersh EM, Gutterman JU, Mavligit GM (1975) Cancer and host defence mechanisms. In: Ioachim HL (ed) Pathobiology annual. Appleton-Century-Crofts, New York, pp 133–167
Hersh EM, Mavligit GM, Gutterman JU (1976) Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient. Med Clin North Am 60:623–639
Koren K, Fabian F, Horvath A, Chylo E, Waltzer I, Filipek P, Adamec K, Hirc B, Vrablik V (1989) The importance of early cholecystectomy in cholelithiasis for the prevention of carcinoma of the gallbladder. Bratisl Lek Listy 90:416
Munster A, Winchurch R, Birmingham W, Keeling P (1980) Longitudinal assay of lymphocyte responsiveness in patients with major burns. Ann Surg 192:772–775
Nakayama F (1991) Recent progress in the diagnosis and treatment of carcinoma of the gallbladder. Introduction. World J Surg 15:313–314
Nervi F, Duarte I, Gómez G, Rodríguez G, Del Pino G, Ferreiro O, Covarrubias C, Valdivieso V, Torres M, Urzúa A (1988) Frequency of gallbladder cancer in Chile, a high risk area. Int J Cancer 41:657–660
Ogura Y, Mizumoto R, Isaji S, Kusuda T, Matsuda S, Tabata M (1991) Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 15:337–343
Sheibani K, Tubbs R (1984) Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol 1:235–250
Wanebo HJ, Castle WN, Fechner RE (1982) Is carcinoma of the gallbladder a curable lesion? Ann Surg 195:624–631
Author information
Authors and Affiliations
Additional information
This work has been financed by grant 422/88 from FONDECYT, Chile.
Rights and permissions
About this article
Cite this article
Cubillos, L., González, S., Sepúlveda, C. et al. Immunological evaluation of patients with invasive carcinoma of the gallbladder. J Cancer Res Clin Oncol 119, 497–500 (1993). https://doi.org/10.1007/BF01215932
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01215932